Table 2.
ORa estimates related to access to the swab for the entire population (N=85,348), stratified by gender and age group (1 model for each variable).
| Variable and category | Male | Female | |||
|
|
Age 45-59 years (n=16,978, 19.9%), OR (95% CI)b | Age 60-74 years (n=15,151, 17.8%), OR (95% CI)b | Age 45-59 years (n=37,694, 44.2%), OR (95% CI)b | Age 60-74 years (n=15,525, 18.1%), OR (95% CI)b | |
| CCIc | |||||
|
|
0 | Reference | Reference | Reference | Reference |
| 1 | 1.37 (1.32-1.43) | 1.31 (1.26-1.37) | 1.22 (1.19-1.26) | 1.39 (1.34-1.45) | |
| 2-3 | 2.41 (2.26-2.56) | 2.31 (2.21-2.42) | 1.37 (1.31-1.45) | 2.19 (2.09-2.30) | |
| 4+ | 4.41 (3.93-4.95) | 4.93 (4.62-5.26) | 2.22 (1.91-2.57) | 5.18 (4.73-5.68) | |
| Oncological disease | 2.31 (2.10-2.53) | 2.04 (1.93-2.15) | 1.18 (1.10-1.27) | 1.80 (1.69-1.92) | |
| Cardiovascular disease | 1.94 (1.84-2.05) | 2.11 (2.03-2.19) | 1.45 (1.37-1.52) | 2.19 (2.09-2.29) | |
| Respiratory disease | 2.41 (2.24-2.59) | 3.20 (3.03-3.37) | 1.68 (1.57-1.79) | 3.34 (3.13-3.55) | |
| Myocardial infarction | 1.57 (1.42-1.74) | 1.71 (1.62-1.81) | 1.53 (1.32-1.77) | 1.94 (1.76-2.14) | |
| Heart failure | 2.45 (2.00-3.00) | 3.07 (2.78-3.40) | 1.71 (1.27-2.29) | 3.28 (2.81-3.83) | |
| Cerebrovascular disease | 2.60 (2.30-2.94) | 2.71 (2.53-2.90) | 1.63 (1.45-1.85) | 3.31 (3.04-3.60) | |
| Diabetes | 1.46 (1.37-1.55) | 1.46 (1.40-1.52) | 1.21 (1.15-1.27) | 1.60 (1.52-1.67) | |
aOR: odds ratio.
bEstimates adjusted for age. All estimates (95% confidence level) were significant.
cCCI: Charlson Comorbidity Index.